Compare ACB & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACB | PDEX |
|---|---|---|
| Founded | 2013 | 1978 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.8M | 197.4M |
| IPO Year | 2016 | 1995 |
| Metric | ACB | PDEX |
|---|---|---|
| Price | $2.67 | $54.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $56.00 |
| AVG Volume (30 Days) | ★ 1.1M | 87.1K |
| Earning Date | 06-17-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 345.00 |
| EPS | N/A | ★ 3.27 |
| Revenue | N/A | ★ $66,593,000.00 |
| Revenue This Year | $6.31 | $7.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.72 |
| Revenue Growth | N/A | ★ 23.68 |
| 52 Week Low | $2.56 | $23.52 |
| 52 Week High | $6.67 | $68.99 |
| Indicator | ACB | PDEX |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | 42.53 |
| Support Level | N/A | $55.29 |
| Resistance Level | $2.74 | $55.62 |
| Average True Range (ATR) | 0.08 | 3.23 |
| MACD | 0.02 | -0.56 |
| Stochastic Oscillator | 44.44 | 23.81 |
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.